{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:44:38Z","timestamp":1787611478436,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jvs.2024.03.449","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:38:12Z","timestamp":1712637492000},"page":"505-514.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Post hoc analysis of the SuperB and Zilverpass trials for treatment of long and complex superficial femoral artery lesions"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-7648","authenticated-orcid":false,"given":"Laurens A.","family":"van Walraven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit\u00f3ria M.","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel J.","family":"Bosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Deloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-1322","authenticated-orcid":false,"given":"Suzanne","family":"Holewijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark J.","family":"Zeebregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-1768","authenticated-orcid":false,"given":"Michel M.P.J.","family":"Reijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2024.03.449_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and Polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2024.03.449_bib2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jvs.2020.10.067","article-title":"Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines","volume":"73","author":"Bath","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib3","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.03.449_bib4","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for vascular surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacc.2022.10.036","article-title":"Revascularization strategies for patients with femoropopliteal peripheral artery disease","volume":"81","author":"Farhan","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.03.449_bib7","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.jcin.2017.09.013","article-title":"1-Year results of a multicenter randomized controlled trial comparing heparin-bonded Endoluminal to femoropopliteal bypass","volume":"10","author":"Reijnen","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.03.449_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1526602820902014","article-title":"ZILVERPASS study: ZILVER PTX stent vs bypass surgery in femoropopliteal lesions","volume":"27","author":"Bosiers","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"issue":"Suppl S","key":"10.1016\/j.jvs.2024.03.449_bib9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society Consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib10","first-page":"562","article-title":"Endovascular bypass as a strategy for long femoropopliteal lesions","volume":"63","author":"van den Hondel","year":"2022","journal-title":"J\u00a0Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jvs.2014.12.062","article-title":"Safety and efficacy of antiplatelet\/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease","volume":"61","author":"Ullery","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.121.054835","article-title":"Effect of rivaroxaban and aspirin in patients with peripheral artery disease undergoing surgical revascularization: Insights from the VOYAGER PAD trial","volume":"144","author":"Debus","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.03.449_bib13","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jvs.2017.07.065","article-title":"Review of aspirin and clopidogrel resistance in peripheral arterial disease","volume":"66","author":"Guirgis","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/1526602817719881","article-title":"Histological evaluation of a self-expanding stent-graft 23 Months after implantation in the superficial femoral artery","volume":"24","author":"Ishihara","year":"2017","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.03.449_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jvs.2012.08.068","article-title":"The outcome of failed endografts inserted for superficial femoral artery occlusive disease","volume":"57","author":"Lensvelt","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jcin.2021.03.030","article-title":"Clinical Impact of stent graft thrombosis in femoropopliteal arterial lesions","volume":"14","author":"Ichihashi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.03.449_bib17","first-page":"1714","article-title":"Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia","volume":"99","author":"Groot Jebbink","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.03.449_bib18","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jvs.2023.01.195","article-title":"Outcome after revascularization with paclitaxel-coated devices in patients with chronic limb-threatening ischemia","volume":"77","author":"Smith","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib19","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jvs.2020.12.061","article-title":"Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions","volume":"73","author":"Tsujimura","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1538574411405548","article-title":"Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease","volume":"45","author":"Schneider","year":"2011","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1526602816666261","article-title":"Comparable 2-year restenosis rates following subintimal and intraluminal drug-eluting stent implantation for femoropopliteal chronic total occlusion","volume":"23","author":"Ishihara","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.03.449_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","article-title":"1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal Practice: Predictors of restenosis and aneurysmal degeneration","volume":"15","author":"Iida","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.03.449_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1526602819860124","article-title":"Vessel Calcification as a risk factor for in-stent restenosis in complex femoropopliteal lesions after Zilver PTX paclitaxel-coated stent placement","volume":"26","author":"Ichihashi","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2024.03.449_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for vascular surgery lower Extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jvs.2022.07.183","article-title":"A\u00a0systematic review and meta-analysis of GLASS staging system in the endovascular treatment of chronic limb-threatening ischemia","volume":"77","author":"Bontinis","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.03.449_bib26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00270-023-03589-6","article-title":"Treatment of complex femoro-popliteal lesions: time to revise the guidelines according to clinical reality","volume":"46","author":"Zeller","year":"2023","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424009364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424009364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:41:09Z","timestamp":1785548469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521424009364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0741521424009364"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2024.03.449","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post hoc analysis of the SuperB and Zilverpass trials for treatment of long and complex superficial femoral artery lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2024.03.449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}